Absorption |
Blood-Brain Barrier | BBB+ | 0.9267 |
Human Intestinal Absorption | HIA+ | 1.0000 |
Caco-2 Permeability | Caco2- | 0.5109 |
P-glycoprotein Substrate | Substrate | 0.5000 |
P-glycoprotein Inhibitor | Inhibitor | 0.5139 |
Inhibitor | 0.9331 |
Renal Organic Cation Transporter | Non-inhibitor | 0.7326 |
Distribution |
Subcellular localization | Mitochondria | 0.8450 |
Metabolism |
CYP450 2C9 Substrate | Non-substrate | 0.7816 |
CYP450 2D6 Substrate | Non-substrate | 0.8188 |
CYP450 3A4 Substrate | Substrate | 0.7218 |
CYP450 1A2 Inhibitor | Non-inhibitor | 0.5452 |
CYP450 2C9 Inhibitor | Inhibitor | 0.6251 |
CYP450 2D6 Inhibitor | Non-inhibitor | 0.8932 |
CYP450 2C19 Inhibitor | Inhibitor | 0.5531 |
CYP450 3A4 Inhibitor | Non-inhibitor | 0.8559 |
CYP Inhibitory Promiscuity | High CYP Inhibitory Promiscuity | 0.6061 |
Excretion |
Toxicity |
Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.9349 |
Non-inhibitor | 0.6465 |
AMES Toxicity | AMES toxic | 0.5565 |
Carcinogens | Non-carcinogens | 0.8731 |
Fish Toxicity | High FHMT | 0.9377 |
Tetrahymena Pyriformis Toxicity | High TPT | 0.8944 |
Honey Bee Toxicity | Low HBT | 0.8137 |
Biodegradation | Not ready biodegradable | 0.9619 |
Acute Oral Toxicity | III | 0.6027 |
Carcinogenicity (Three-class) | Non-required | 0.6051 |